B+
Bull case
25%
Probability
Target price
$5.40
Analysis reference price unavailable
Analysis 2026-08-17 · RankAlpha Sentiment Codex
MNKD
MannKindBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Revenue grew 43% year over year, commercial-product revenue is diversifying, ReadyFlow has regulatory approval, pediatric Afrezza access is expanding, and the pipeline advanced with positive MNKD-201 data. [#SEC-8K-2026-08-05]
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +0.7.
What can break
A $45 million CVR payment is expected in Q3, creating near-term cash-flow pressure.
Momentum
30
Value
51
Sentiment
75
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $4.50 · Bull $5.40 · Bear $2.80Analysis 2026-08-17; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-17 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $7.97
Why
Momentum30 · Δ7d +6.9
Value51 · Δ7d -0.0
Sentiment75 · Δ7d +0.7
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta +0.7.
Contradictions & invalidation
- • A $45 million CVR payment is expected in Q3, creating near-term cash-flow pressure.
- • Afrezza adult demand remained soft while pediatric conversion and payer access are still developing.
- • Execution must convert approvals into durable demand while absorbing launch costs, elevated operating expenses, higher FUROSCIX gross-to-net adjustments, a $45 million CVR payment, and a reported GAAP loss.
Catalyst clock
2026-08-31
FUROSCIX ReadyFlow commercial launch
Lead driver: Sentiment · See AI snapshot
Momentum
30
9% active weight
Current posture
7d trendImproving
Δ7d
+6.9
Δ21d
-16.9
Value
51
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
-10.3
Sentiment
75
62% active weight
Current posture
7d trendFlat
Δ7d
+0.7
Δ21d
-0.9
Why this grade
Composite grade B. Momentum 29.9 / Value 51.3 / Sentiment 74.8
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-17. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$4.50
Analysis reference price unavailable
Analysis 2026-08-17 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$2.80
Analysis reference price unavailable
Analysis 2026-08-17 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$1.25B
Beta
0.84
Shares Out
321.54M
P/E (TTM)
60.7
P/S (TTM)
5.50
P/FCF (TTM)
39.77
Rev YoY
+42.9%
EPS YoY
-3033.3%
Gross Margin
+72.2%
Op Margin
+3.4%
Net Debt
$302.04M
Current Ratio
1.72
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data